INGR - Ingredion Incorporated
NYSE
->
Consumer Defensive
->
Packaged Foods
Westchester,
United States
Type: Equity
INGR price evolution
INGR
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $505 | $438 | $401 | |
| Short term investments | $5 | $7 | $8 | |
| Net receivables | $1173 | $1286 | $1284 | $1279 |
| Inventory | $1234 | $1244 | $1344 | $1450 |
| Total current assets | $3351 | $3099 | $3125 | $3399 |
| Long term investments | ||||
| Property, plant & equipment | $2332 | $2291 | $2334 | $2370 |
| Goodwill & intangible assets | $1275 | $1286 | $1303 | |
| Total noncurrent assets | $4122 | $4194 | $4243 | |
| Total investments | $5 | $7 | $8 | |
| Total assets | $7525 | $7221 | $7319 | $7642 |
| Current liabilities | ||||
| Accounts payable | $606 | $659 | $778 | |
| Deferred revenue | ||||
| Short long term debt | $109 | $141 | $448 | |
| Total current liabilities | $1255 | $1230 | $1283 | $1772 |
| Long term debt | $1741 | $1741 | $1740 | $1740 |
| Total noncurrent liabilities | $2212 | $2211 | $2220 | |
| Total debt | $1850 | $1881 | $2188 | |
| Total liabilities | $3575 | $3442 | $3494 | $4104 |
| Shareholders' equity | ||||
| Retained earnings | $5049 | $4914 | $4818 | $4654 |
| Other shareholder equity | -$1000 | -$1118 | -$1062 | -$1056 |
| Total shareholder equity | $3705 | $3724 | $3538 | |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $401 | $236 | $328 | $665 |
| Short term investments | $8 | $3 | $4 | |
| Net receivables | $1279 | $1411 | $1130 | $1011 |
| Inventory | $1450 | $1597 | $1172 | $917 |
| Total current assets | $3399 | $3309 | $2697 | $2647 |
| Long term investments | ||||
| Property, plant & equipment | $2370 | $2407 | $2423 | $2628 |
| Goodwill & intangible assets | $1303 | $1301 | $1348 | $1346 |
| Total noncurrent assets | $4243 | $4252 | $4302 | $4211 |
| Total investments | $8 | $3 | $4 | |
| Total assets | $7642 | $7561 | $6999 | $6858 |
| Current liabilities | ||||
| Accounts payable | $778 | $1339 | $774 | $599 |
| Deferred revenue | ||||
| Short long term debt | $448 | $543 | $308 | $438 |
| Total current liabilities | $1772 | $1882 | $1512 | $1458 |
| Long term debt | $1740 | $1940 | $1738 | $1884 |
| Total noncurrent liabilities | $2220 | $2417 | $2262 | $2328 |
| Total debt | $2188 | $2483 | $2046 | $2322 |
| Total liabilities | $4104 | $4414 | $3774 | $3786 |
| Shareholders' equity | ||||
| Retained earnings | $4654 | $4210 | $3899 | $3957 |
| Other shareholder equity | -$1056 | -$1048 | -$897 | -$1133 |
| Total shareholder equity | $3538 | $3147 | $3100 | $2951 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1870 | $1878 | $1921 | |
| Cost of revenue | $1432 | |||
| Gross Profit | $479 | $446 | $400 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $191 | |||
| Total operating expenses | $199 | $206 | $197 | |
| Operating income | $240 | |||
| Income from continuing operations | ||||
| EBIT | $238 | |||
| Income tax expense | $84 | $80 | $43 | |
| Interest expense | -$1 | $10 | -$26 | |
| Net income | ||||
| Net income | $188 | $148 | $131 | |
| Income (for common shares) | $148 | |||
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $8160 | $7946 | $5987 | |
| Cost of revenue | $6452 | $4715 | ||
| Gross Profit | $1749 | $1494 | $1272 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $715 | $628 | ||
| Total operating expenses | $781 | $732 | $721 | |
| Operating income | $762 | $551 | ||
| Income from continuing operations | ||||
| EBIT | $757 | $581 | ||
| Income tax expense | $188 | $166 | $152 | |
| Interest expense | -$114 | $99 | $81 | |
| Net income | ||||
| Net income | $643 | $492 | $348 | |
| Income (for common shares) | $492 | $348 | ||
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Net income | $148 | $216 | ||
| Operating activities | ||||
| Depreciation | $54 | $53 | ||
| Business acquisitions & disposals | $247 | |||
| Stock-based compensation | ||||
| Total cash flows from operations | $312 | $209 | ||
| Investing activities | ||||
| Capital expenditures | -$55 | -$65 | ||
| Investments | ||||
| Total cash flows from investing | $79 | -$56 | $181 | -$329 |
| Financing activities | ||||
| Dividends paid | -$156 | -$53 | -$51 | -$194 |
| Sale and purchase of stock | -$56 | $1 | ||
| Net borrowings | -$30 | -$297 | ||
| Total cash flows from financing | -$601 | -$179 | -$347 | -$569 |
| Effect of exchange rate | -$2 | -$10 | -$6 | $6 |
| Change in cash and equivalents | $476 | $67 | $37 | $165 |
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $492 | $117 | $348 | |
| Operating activities | ||||
| Depreciation | $215 | $220 | $213 | |
| Business acquisitions & disposals | -$29 | -$40 | -$242 | |
| Stock-based compensation | ||||
| Total cash flows from operations | $152 | $392 | $829 | |
| Investing activities | ||||
| Capital expenditures | -$293 | -$282 | -$333 | |
| Investments | $4 | |||
| Total cash flows from investing | -$329 | -$320 | -$335 | -$571 |
| Financing activities | ||||
| Dividends paid | -$194 | -$181 | -$184 | -$178 |
| Sale and purchase of stock | -$103 | -$49 | $4 | |
| Net borrowings | $433 | -$140 | $317 | |
| Total cash flows from financing | -$569 | $103 | -$373 | $143 |
| Effect of exchange rate | $6 | -$27 | -$21 | |
| Change in cash and equivalents | $165 | -$92 | -$337 | $401 |
News
Fundamentals
| Market cap | $9.40B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 65.10M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | -8.02% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.16 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.67 |
| Quick ratio | 1.69 |